Localization of decay accelerating factor in normal and diseased kidneys
- 1 July 1989
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 36 (1) , 100-107
- https://doi.org/10.1038/ki.1989.167
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Signal for Attachment of a Phospholipid Membrane Anchor in Decay Accelerating FactorScience, 1987
- Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids.The Journal of Experimental Medicine, 1987
- Decay-accelerating factor is present on cultured human umbilical vein endothelial cells.The Journal of Experimental Medicine, 1986
- Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.The Journal of Experimental Medicine, 1985
- Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor.Proceedings of the National Academy of Sciences, 1985
- Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.The Journal of Experimental Medicine, 1984
- Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.Proceedings of the National Academy of Sciences, 1983
- Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.Proceedings of the National Academy of Sciences, 1983
- Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.Journal of Clinical Investigation, 1983